MedPath

SOTIO Biotech a.s.

🇨🇿Czech Republic
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic Adenocarcinoma

Phase 1
Terminated
Conditions
Pancreatic Cancer
Interventions
First Posted Date
2022-09-01
Last Posted Date
2025-01-13
Lead Sponsor
SOTIO Biotech a.s.
Target Recruit Count
44
Registration Number
NCT05525286
Locations
🇺🇸

Washington University School of Medicine in St. Louis, Saint Louis, Missouri, United States

🇧🇪

Universitair Ziekenhuis Leuven - Campus Gasthuisberg, Leuven, Belgium

🇪🇸

VHIO - Vall d'Hebron Institut d'Oncologia, Barcelona, Spain

and more 5 locations
© Copyright 2025. All Rights Reserved by MedPath